% IMPORTANT: The following is UTF-8 encoded.  This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.

@ARTICLE{Galldiks:1024009,
      author       = {Galldiks, Norbert and Kaufmann, Timothy J and Vollmuth,
                      Philipp and Lohmann, Philipp and Smits, Marion and Veronesi,
                      Michael C and Langen, Karl-Josef and Rudá, Roberta and
                      Albert, Nathalie L and Hattingen, Elke and Law, Ian and
                      Hutterer, Markus and Soffietti, Riccardo and Vogelbaum,
                      Michael A and Wen, Patrick Y and Weller, Michael and Tonn,
                      Joerg-Christian},
      title        = {{C}hallenges, {L}imitations and {P}itfalls of {PET} and
                      {A}dvanced {MRI} in {P}atients with {B}rain {T}umors - {A}
                      {R}eport of the {PET}/{RANO} {G}roup},
      journal      = {Neuro-Oncology},
      volume       = {26},
      number       = {7},
      issn         = {1522-8517},
      address      = {Oxford},
      publisher    = {Oxford Univ. Press},
      reportid     = {FZJ-2024-01908},
      pages        = {1181-1194},
      year         = {2024},
      abstract     = {Brain tumor diagnostics have significantly evolved with the
                      use of positron emission tomography (PET) and advanced
                      magnetic resonance imaging (MRI) techniques. In addition to
                      anatomical MRI, these modalities may provide valuable
                      information for several clinical applications such as
                      differential diagnosis, delineation of tumor extent,
                      prognostication, differentiation between tumor relapse and
                      treatment-related changes, and the evaluation of response to
                      anticancer therapy. In particular, joint recommendations of
                      the Response Assessment in Neuro-Oncology (RANO) Group, the
                      European Association of Neuro-oncology, and major European
                      and American Nuclear Medicine societies highlighted that the
                      additional clinical value of radiolabeled amino acids
                      compared to anatomical MRI alone is outstanding and that its
                      widespread clinical use should be supported. For advanced
                      MRI and its steadily increasing use in clinical practice,
                      the Standardization Subcommittee of the Jumpstarting Brain
                      Tumor Drug Development Coalition provided more recently an
                      updated acquisition protocol for the widely used dynamic
                      susceptibility contrast perfusion MRI. Besides amino acid
                      PET and perfusion MRI, other PET tracers and advanced MRI
                      techniques (e.g. MR spectroscopy) are of considerable
                      clinical interest and are increasingly integrated into
                      everyday clinical practice. Nevertheless, these modalities
                      have shortcomings which should be considered in clinical
                      routine. This comprehensive review provides an overview of
                      potential challenges, limitations, and pitfalls associated
                      with PET imaging and advanced MRI techniques in patients
                      with gliomas or brain metastases. Despite these issues, PET
                      imaging and advanced MRI techniques continue to play an
                      indispensable role in brain tumor management. Acknowledging
                      and mitigating these challenges through interdisciplinary
                      collaboration, standardized protocols, and continuous
                      innovation will further enhance the utility of these
                      modalities in guiding optimal patient care.},
      cin          = {INM-3},
      ddc          = {610},
      cid          = {I:(DE-Juel1)INM-3-20090406},
      pnm          = {5252 - Brain Dysfunction and Plasticity (POF4-525)},
      pid          = {G:(DE-HGF)POF4-5252},
      typ          = {PUB:(DE-HGF)16},
      pubmed       = {38466087},
      UT           = {WOS:001196533900001},
      doi          = {10.1093/neuonc/noae049},
      url          = {https://juser.fz-juelich.de/record/1024009},
}